Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Barriers and Facilitators to Exercise for Individuals With Autoimmune Myasthenia Gravis, Congenital Myasthenic Syndrome or Lambert-Eaton Myasthenic Syndrome in France: a Descriptive, Cross-sectional Study

NCT05408702 is registered in ClinicalTrials.gov with Institut de Myologie, France as lead sponsor.

NCT NCT05408702
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05408702 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Barriers and Facilitators to Exercise for Individuals With Autoimmune Myasthenia Gravis, Congenital Myasthenic Syndrome or Lambert-Eaton Myasthenic Syndrome in France: a Descriptive, Cross-sectional Study
Lead sponsor
Institut de Myologie, France
Phase
Observational
Overall status
Completed
Start date
November 12, 2021
Completion date
May 15, 2022
Enrollment
500 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

autoimmune myasthenia gravis, congenital myasthenic syndrome, lambert-eaton myasthenic syndrome, myasthenia gravis